[ Ссылка ]
A simple RA drug that can cut down the risk of heart attacks and strokes… next
First-Line RA Drug Linked to Decreased CVD Risk
Kate Johnson writing for Medpage Today reported the antimalaria drug hydroxychloroquine (Plaquenil) that is used as first-line therapy in patients with rheumatoid arthritis (RA) is also associated with reduced cardiovascular risk, especially at higher doses, a new study shows.
"This is the first study to answer this question specifically," said Michael Shapiro, MD, from the Sackler Faculty of Medicine\ at Tel Aviv University in Israel, who suggested a "protective effect" of the drug.
The retrospective analysis included 514 RA patients ages 18 years or older who were treated at a single institution between 2003 and 2013.
Comment: I use Plaquenil sparingly for patients with mild RA. Nonetheless this study shows that even a mild drug can have beneficial effects.
[ Ссылка ]
